Welichem Biotech Competitors and Similar CompaniesClear all
Welichem Biotech's competitors and similar companies include Vyripharm Biopharmaceuticals, Pharmacyclics, HUYA Bioscience International and Ascendis Pharma.
 Welichem Biotech Welichem BioTech is a biotech company focused on developing autoimmune inflammatory disease and cancer pharmaceutical drugs. |  Vyripharm Biopharmaceuticals Vyripharm Biopharmaceuticals is a company focused on developing treatments for neurological disorders and infectious diseases. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | |
Founding Date | Founding Date N/A | Founding Date 2019 | Founding Date 1991 | Founding Date 2004 | Founding Date 2007 |
Type | Type Private | Type Subsidiary | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Vancouver, CA HQ | Locations Dallas, US HQ | Locations Sunnyvale, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US |
Employees | Employees 1 | Employees 5 | Employees 6551% decrease | Employees 1113% increase | Employees 1,017 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) N/A | Revenue (est.) €720.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) | Cost of goods N/A | Cost of goods €93.1m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $689.3m (FY, 2014) | Gross profit N/A | Gross profit €627.1m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income $86.1m (FY, 2014) | Net income N/A | Net income (€228m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 12.6m | Total funding raised $ 85.8m |
For sources of this data, please see the company profile
View Company Profiles
Vyripharm Biopharmaceuticals
HQ
Dallas, US
Vyripharm Biopharmaceuticals is a company focused on developing treatments for neurological disorders and infectious diseases.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View companyHUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View companyAscendis Pharma
HQ
Hellerup, DK
Employees
1,017
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company